Africa Corporate Wellness Market, by End User, 2018-2027
Global Automated Cell Culture market [2017-2027] Asia Pacific by Application
By Application, the market is segmented into Biopharmaceutical Production, Tissue Engineering & Regenerative Medicine, Drug Screening and Development, Gene therapy, Stem Cell Research, Diagnostics, Toxicity testing, and Others (2017-2027)
| Label | Biopharmaceutical Production | Tissue Engineering & Regenerative Medicine | Drug Screening and Development | Gene therapy | Stem Cell Research | Diagnostics | Toxicity testing | Others |
|---|---|---|---|---|---|---|---|---|
| 2017 | 340.7 USD Mn | 268.7 USD Mn | 252.1 USD Mn | 182.6 USD Mn | 178.1 USD Mn | 129.0 USD Mn | 114.9 USD Mn | 84.9 USD Mn |
| 2018 | 370.5 USD Mn | 291.9 USD Mn | 275.3 USD Mn | 199.2 USD Mn | 185.1 USD Mn | 140.6 USD Mn | 124.7 USD Mn | 92.0 USD Mn |
| 2019 | 402.7 USD Mn | 316.9 USD Mn | 300.3 USD Mn | 217.3 USD Mn | 192.8 USD Mn | 153.1 USD Mn | 135.2 USD Mn | 99.5 USD Mn |
| 2020 | 438.7 USD Mn | 344.9 USD Mn | 328.4 USD Mn | 237.6 USD Mn | 201.9 USD Mn | 167.0 USD Mn | 146.9 USD Mn | 107.8 USD Mn |
| 2021 | 476.9 USD Mn | 374.7 USD Mn | 358.4 USD Mn | 259.2 USD Mn | 212.1 USD Mn | 181.7 USD Mn | 159.1 USD Mn | 116.0 USD Mn |
| 2022 | 520.7 USD Mn | 408.8 USD Mn | 392.7 USD Mn | 284.1 USD Mn | 225.0 USD Mn | 198.7 USD Mn | 172.7 USD Mn | 125.1 USD Mn |
| 2023 | 569.5 USD Mn | 446.7 USD Mn | 431.0 USD Mn | 311.8 USD Mn | 240.1 USD Mn | 217.5 USD Mn | 187.7 USD Mn | 134.9 USD Mn |
| 2024 | 622.9 USD Mn | 487.9 USD Mn | 473.2 USD Mn | 342.3 USD Mn | 258.4 USD Mn | 238.1 USD Mn | 203.4 USD Mn | 145.1 USD Mn |
| 2025 | 681.9 USD Mn | 531.9 USD Mn | 520.0 USD Mn | 376.2 USD Mn | 281.2 USD Mn | 260.9 USD Mn | 220.5 USD Mn | 155.9 USD Mn |
| 2026 | 752.9 USD Mn | 583.9 USD Mn | 576.2 USD Mn | 417.0 USD Mn | 312.5 USD Mn | 288.3 USD Mn | 240.9 USD Mn | 168.8 USD Mn |
| 2027 | 832.0 USD Mn | 642.5 USD Mn | 641.7 USD Mn | 464.4 USD Mn | 356.1 USD Mn | 320.1 USD Mn | 263.7 USD Mn | 183.5 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The 2027] Asia Pacific by Application portion of the Global Automated Cell Culture market [2017 market is on a steady long-term growth path. Segment value stands at roughly USD 3341 Mn in 2026 and is projected to reach USD 3704 Mn by 2027 — a gain of about 11% over the forecast period, translating to a CAGR in the double digits.
- biopharmaceutical production segment accounted for the largest market share in 2019, this market is expected to reach USD 832. 00 Million in 2027 from USD 402.
- What the regional split looks like (2026): Biopharmaceutical Production leads, holding roughly 23% of segment value — the single largest regional share. Tissue Engineering & Regenerative Medicine is the second-largest contributor. Drug Screening and Development, Gene therapy, Stem Cell Research, Diagnostics, Toxicity testing and Others make up the remainder, in descending order.
- By 2027, Biopharmaceutical Production alone is expected to reach USD 832 Mn, with Tissue Engineering & Regenerative Medicine at USD 643 Mn.
Market Dynamics
biopharmaceutical production segment accounted for the largest market share in 2019, this market is expected to reach USD 832.00 Million in 2027 from USD 402.70 Million in 2019. This market is projected to grow at a CAGR of 9.57% during the forecast period from 2020 - 2027. However, gene therapy segment is the fastest growing market, which is expected to grow at a CAGR of 10.05% during the forecast period 2020 - 2027.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



